PER 1.41% 7.0¢ percheron therapeutics limited

One Study Away, page-35

  1. 38 Posts.
    lightbulb Created with Sketch. 4
    After a few weeks of DD and individual investigation, I have bought into the company. I’m quietly confident this trial will go well and the market cap is just way to low.

    My only concern is the current CEO, however I believe that with there is a much greater risk/reward which outweighs any of my concerns.

    Very excited to be apart of this, and I’m in for a long and fun (and hopefully profitable) ride!

    All IMO
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.